Lebovics E, Palmer M, Woo J, Schaffner F
Arch Intern Med. 1987 Apr;147(4):729-31.
The natural history and prognostic factors of primary sclerosing cholangitis (PSC) are poorly defined. We reviewed our experience with PSC to determine its natural history and whether any factors on presentation or during follow-up were indicative of a favorable or unfavorable prognosis. Thirty-eight patients were followed up for 75.1 +/- 58.7 months; 17 (45%) had a poor outcome, defined as the occurrence of death (11 patients [29%]), variceal hemorrhage, hepatic encephalopathy, or hepatic transplantation. We found the following: the rate of progression of PSC is highly variable; an asymptomatic presentation may not indicate a more favorable outcome or prolonged survival; a serum bilirubin value of four times or more the upper limit of normal, particularly if sustained so as to exclude a reversible cause, is indicative of late-stage disease with a likelihood of subsequent poor outcome and death; and variceal hemorrhage may occur before the terminal stage of the disease.
原发性硬化性胆管炎(PSC)的自然病史和预后因素尚未明确界定。我们回顾了我们治疗PSC的经验,以确定其自然病史,以及初诊时或随访期间的任何因素是否表明预后良好或不良。38例患者接受了75.1±58.7个月的随访;17例(45%)预后不良,定义为发生死亡(11例[29%])、静脉曲张出血、肝性脑病或肝移植。我们发现以下情况:PSC的进展速度差异很大;无症状表现可能并不意味着预后更好或生存期更长;血清胆红素值为正常上限的四倍或更高,特别是如果持续如此以排除可逆性病因,则表明处于疾病晚期,随后预后不良和死亡的可能性较大;并且静脉曲张出血可能在疾病终末期之前发生。